Yuyu Pharma Inc (000227) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Yuyu Pharma Inc (000227) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million ≈ $566.97K USD) by net assets (₩139.10 Billion ≈ $94.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Yuyu Pharma Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Yuyu Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Yuyu Pharma Inc debt and liabilities for a breakdown of total debt and financial obligations.

Yuyu Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Adaptimmune Therapeutics plc F:473A	0.490x
Oceanpal Inc NASDAQ:OP	-0.007x
Hyungkuk F&B Co Ltd KQ:189980	0.069x
Estoril Sol SGPS SA LS:ESON	0.084x
Imago Mulia Persada Tbk PT JK:LFLO	-0.132x
FRANCHETTI S.P.A. F:D0E	N/A
AXIOS Sustainable Growth NYSE:AXAC	-0.003x
Cengild Medical Berhad KLSE:0243	0.008x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Yuyu Pharma Inc worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	--

About Yuyu Pharma Inc

KO:000227 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$42.93 Million

₩63.34 Billion KRW

Market Cap Rank

#22445 Global

#1518 in Korea

Share Price

₩10810.00

Change (1 day)

-0.37%

52-Week Range

₩9900.00 - ₩11670.00

All Time High

₩56262.57